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Contact dermatitis tremendously impacts the quality of life of
suffering patients. Currently, diagnostic regimes rely on allergy
testing, exposure specification, and follow-up visits; however, dis-
tinguishing the clinical phenotype of irritant and allergic contact
dermatitis remains challenging. Employing integrative transcrip-
tomic analysis and machine-learning approaches, we aimed to de-
cipher disease-related signature genes to find suitable sets of
biomarkers. A total of 89 positive patch-test reaction biopsies
against four contact allergens and two irritants were analyzed
via microarray. Coexpression network analysis and Random Forest
classification were used to discover potential biomarkers and se-
lected biomarker models were validated in an independent patient
group. Differential gene-expression analysis identified major
gene-expression changes depending on the stimulus. Random For-
est classification identified CD47, BATF, FASLG, RGS16, SYNPO,
SELE, PTPN7, WARS, PRC1, EXO1, RRM2, PBK, RAD54L, KIFC1,
SPC25, PKMYT, HISTH1A, TPX2, DLGAP5, TPX2, CH25H, and IL37
as potential biomarkers to distinguish allergic and irritant contact
dermatitis in human skin. Validation experiments and prediction
performances on external testing datasets demonstrated potential
applicability of the identified biomarker models in the clinic. Cap-
italizing on this knowledge, novel diagnostic tools can be devel-
oped to guide clinical diagnosis of contact allergies.
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Occupational skin disorders continue to be an importantwork-related disease, being ranked among the top five oc-
cupational diseases in many industrialized countries (1). Contact
dermatitis (CD), representing over 90% of occupational skin
disorders, causes a significant percentage of work disabilities and
a great number of lost workdays, thus it has significant socio-
economic impact (2, 3). Patients suffering from CD can develop
a considerable physical handicap leading to reduced quality of
life (4).
Two major groups of CD are recognized, namely allergic
contact dermatitis (ACD) and irritant contact dermatitis (ICD).
ACD is a type IV hypersensitivity reaction that arises from
topical exposure to agents with sensitizing potential. In contrast,
ICD is caused by direct damage to the skin by exposure to
physical or chemical agents, resulting in a nonspecific inflam-
matory skin reaction (5).
Clinical differentiation of ICD and ACD remains a challeng-
ing field in allergology and dermatology. Diagnostic practices
include clinical history, physical examination, and diagnostic
patch testing. Although patch testing is the current gold standard
for ACD diagnosis, subjective clinical interpretation cannot be
straightforward and standardized; thus, this approach is prone to
errors leading to repeated and additional tests. Therefore,
making an appropriate diagnosis and identifying the causative
agents is of the greatest importance for proper therapeutic and
preventive measures. Currently, available methods for fast and
reliable diagnostics are insufficient or even lacking (6).
Several previous studies shed light on pathological processes
during CD, identifying a diverse repertoire of biomarkers that
can be used to characterize genetic susceptibility and inflammatory
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conditions in general (7–9). However, the plentitude of contact
sensitizers and irritants represents a major challenge in the identi-
fication of robust and valid biomarkers. Furthermore, although
ACD and ICD are mechanistically dissimilar, irritancy and allergy
have multifarious features in common, sharing effector pathways,
inflammatory mediators, cell recruitment, as well as cell-death–
related phenomena (10). Therefore, simultaneous analysis of a
broad range of causative agents may facilitate the identification
of valuable biomarkers.
Herein, we performed patch testing using four contact sensi-
tizers and two irritants with widely different physicochemical
properties and high relevance to occupational exposures. Employing
integrative transcriptome analysis and machine-learning approaches,
we aimed to identify composite gene signatures for contact sensitizers
and irritants, allowing a distinction between the two highly inter-
twined disease subtypes to unravel novel molecular biomarkers.
Results
Molecular Profiling of Contact Sensitizers and Irritants. Positive patch
test reactions to the sensitizers methylchloroisothiazolinone/
methylisothiazolinone (CM), paraphenylenediamine (PP), epoxy
resin, bisphenol A (EP), or nickel (NI), and irritant substances
nonanoic acid (NO) or sodium lauryl sulfate (SL), were collected
at 48 h postexposure from the patch test areas for analyses
according to the scheme in Fig. 1A. The intensities of the allergic
test reactions were rated using a scale of +, ++, or +++, con-
forming to the European guidelines on diagnostic patch testing
(11). For the purpose of this study, irritants were rated as IR0
(slight erythema), IR (standard irritant reaction), IR1 (strong ir-
ritant reaction), and IR2 (very strong irritant reaction). Repre-
sentative images and descriptions of clinical grading can be found
in SI Appendix (SI Appendix, Fig. S1).
Skin biopsy sample collection was followed by RNA extraction
and analysis of global gene-expression levels. Differential gene-
expression analysis identified 3,367 differentially expressed genes
(DEGs) between CM and baseline (BL), 2,853 DEGs between
EP and BL, 2,662 DEGs between NI and BL, 1,831 DEGs be-
tween PP and BL, 1,507 DEGs between SL and BL, and 748
DEGs between NO and BL (Fig. 1B). Analysis of the extent of
overlap between the groups revealed that the four tested contact
sensitizers—PP, NI, EP, and CM—had the largest number of
DEGs in common (641), indicating that these substances induce
highly similar molecular perturbations during the elicitation
phase, regardless of distinct chemical properties. In contrast, the
two tested irritants, NO and SL, shared substantially fewer
DEGs (339) with one another (Fig. 1C and SI Appendix, Fig. S2),
indicating more heterogeneous reaction types. Notably, SL re-
actions shared 502 DEGs with the contact sensitizers, indicating
a higher degree of similarities with contact sensitizers.
Moreover, CM induced the largest number of unique DEGs
(475), and NI the second largest number (234). All six exposures,
including contact sensitizers and irritant substances, induced 152
common DEGs, which could be perceived as a core skin in-
flammatory response regardless of the type of exposure.
Contact Sensitizers and Irritants Cause Leukocyte Compositional
Changes. For further analysis of involved cell subsets, we
employed a leukocyte deconvolution algorithm, which revealed
the accumulation, activation, and polarization of various immune
cells in the two investigated types of skin inflammation, allergies
or irritant reactions, based on the cutaneous gene-expression
profiles. In line with our immunohistochemical analyses, the
analysis predicted significant accumulation of T cells in the ex-
posed samples, including CD4+ and CD8+ activated memory and
naive T cells. Moreover, the proportion of γδ T cells remained
steady across the groups, while T regulatory cells appeared to be
absent in all groups except BL. The allergic skin reactions were
characterized by a significant accumulation of macrophages,
particularly the proinflammatory M1 subset. Notably, there was a
significant accumulation of natural killer (NK) cells, as well as
activated mast cells, along with the disappearance of resting mast
cells. In contrast, irritant reactions displayed a significant decrease
in the proportions of resting mast cells and increased proportions
of monocytes and T cells (Fig. 2 and SI Appendix, Fig. S3).
Remarkably, our findings are mirrored within the functional
enrichment. Pathways such as “Th1 and Th2 signaling,” “Role of
macrophages,” and “Natural killer cell signaling” were highly
enriched in the gene signatures of each contact sensitizer (SI
Appendix, Fig. S4). Moreover, we observed the enrichment of
“Aryl Hydrocarbon receptor signaling” in the gene signatures of
all exposures. The irritant-induced gene-expression profiles were
overrepresented mainly by genes involved in cell cycling (SI
Appendix, Figs. S4 and S5A), and to a lesser extent by
inflammation-related genes. Similar to the sensitizers, SL stim-
ulated both T cell and dendritic cell activation (SI Appendix, Fig.
S5B), however, at a significantly lower level compared to the
contact sensitizers. Genes that were most potently stimulated by
contact sensitizers included MMP12 and GZMB, while irritants
induced S100 protein-coding genes several folds compared with
baseline samples (SI Appendix, Fig. S6).
Contact Sensitizers and Irritants Induce Different Transcriptomic
Profiles. To further examine the extent of similarities and dif-
ferences between the six exposure groups, we explored the
grouping of the transcriptomes, using principal component
analysis (PCA) and the k-means algorithm. Using PCA prior to
cluster analysis is essential for building robust clustering results
(12). Therefore, the PCA procedure was applied first, for pro-
jecting high-dimensional gene-expression data into a low-
dimensional space, revealing trends in the grouping of ACD
and ICD samples. Then, to obtain a clustering result, the
k-means algorithm was applied to the first two principal com-
ponents (PCs), which capture most of the variation in the orig-
inal dataset. k-means clustering was computed several times by
varying k from 1 to 10 clusters (or groups) for different values of
k, and the best k was selected based on the maximum average
silhouette. Visualization of the results by PCA, revealed three
groups clearly separated from each other, including BL, ICD,
and ACD, respectively (Fig. 3A). Notably, the reactions clustered
further according to severity, with the strongest reactions accu-
mulated to the left in each category (SI Appendix, Table S1).
Hierarchical clustering revealed a similar grouping of exposures
into three categories (Fig. 3B), and thus both hierarchical and
nonhierarchical clustering algorithms demonstrated the presence
of three main clusters. Analysis of the enrichment of biological
functions based on gene signatures within each category revealed
overrepresentation of gene ontology (GO) terms, such as
“cytokine-mediated signaling pathway,” “inflammatory re-
sponse,” and “T cell activation” within ACD, and “peptide cross-
linking” and “keratinocyte differentiation” within ICD (SI Ap-
pendix, Table S2). Top up- and down-regulated genes within the
categories are shown in SI Appendix, Table S3, and a Venn di-
agram in Fig. 3C illustrates overlaps between DEGs within ICD
and ACD relative to BL.
Network Analysis Reveals Key Features That Distinguish between
Responses to Contact Sensitizers and Irritants. For further analysis
of the importance of specific genes and clusters of functions in
allergic and irritant inflammatory responses, molecular coex-
pression networks based on the transcriptomes of the single
categories, ACD and ICD, were inferred using the novel tool
inference of network response modules (INfORM) (13). The
INfORM platform allows data-driven learning of regulatory
connections where the algorithm identifies gene modules asso-
ciated with function, and calculates the importance of genes
within each module, based on centrality scores, fold change, and
































P values. We used all of the genes that were identified as sig-
nificantly different between ACD and BL samples, and created a
gene network (Fig. 4A). Genes were considered as linked in the
network if their expression profiles were significantly correlated,
and modules were defined based on the similarity of the gene-
expression profiles, resulting in 13 modules. Each module of
coexpressed genes contributed to specific aspects of ACD patho-
physiology, including “cytokine-mediated signaling,” “adaptive
immune response,” “antigen processing and presentation,” and
“epidermis development.” The analysis revealed that modules
enriched for immune signaling contained mostly up-regulated
genes, whereas modules that were overrepresented by, for exam-
ple, skin development, were predominantly down-regulated
(Fig. 4A and Dataset S1). The corresponding ICD network
(Fig. 4B and Dataset S2) comprised modules enriched for “in-
flammatory response,” “antimicrobial humoral response,” “cell
division,” and “keratinocyte differentiation,” displaying a different
pattern of up- and down-regulation compared with the ACD
network. INfORM algorithms ranked ADAM8, GPR65, CLEC4A,
GPR183, and CD47 as most important genes in the ACD net-
works, and MELK, CDK1, and RRM2 in the networks of ICD
(Datasets S1 and S2). Finally, network inference based on the
contrast between ACD and ICD revealed four modules enriched
for cornification, cell division, immune signaling, and chemotaxis
(SI Appendix, Fig. S7), and ADAM8, BATF, BATF3, and IL13
were ranked as the most important genes (Dataset S3). The
analysis revealed up-regulation of immune signaling, and down-
regulation of cornification, keratinization, and cell division in
ACD compared to ICD (Dataset S3).
Genetic Algorithm-Based Feature Selection Provides Biomarker
Models to Distinguish ACD from ICD. Our observations in the
above analyses strongly supported the possibility of discovering
biomarkers based on the transcriptomes, with a capacity to dis-
criminate between the three categories: BL, ACD, and ICD.
Therefore, we applied a biomarker discovery method, namely
GARBO, which utilizes a genetic algorithm (GA) that is coupled
with a Random Forest (RF) -based classifier (GA-RF) to opti-
mize the number of features when testing the accuracy of omics-
based biomarker panels. If the given classification task can be
solved by using only one gene (or molecular feature), then the




















































Total n = 49
11 BL (9 HS)
7 ICD
13 ACD
















































 n = 7
QC
 n = 89
Fig. 1. Overview of the study scheme and numbers of DEGs in human skin after exposure to allergens and irritants. (A) Schematic illustration of the study
design, including total number of study participants (leftmost panel) and number of samples included in each assay (all other panels). Biomarker validation
was performed at three levels: Technical (samples used in microarray) and biological validation (independent group of patients) by real-time qPCR, and
external validation by testing the performance of the identified biomarkers (external datasets). (B) Numbers of DEGs, including the total number of genes,
number of down- and up-regulated genes, and the number and ratio of unique genes. (C) Venn diagram depicting overlaps between exposure groups.






















GA-RF approach was evaluated with fivefold cross-validation in
order to estimate more robust classification performances. Using
this approach, we discovered 28 novel gene sets, exhibiting high
testing accuracy between BL, ACD, and ICD (Table 1). These
gene sets employed two to three genes, which classified ACD,
ICD, and BL, with an accuracy ranging between 86% and 94%.
We also compiled performance metrics of each class, such as
precision, recall, and F1-score, in order to investigate the per-
formance of the selected biomarker models with respect to the
individual classes: ACD, ICD, and BL (Table 1). We found that
the biomarker models selected by GARBO could accurately
distinguish ACD from ICD. Indeed, the F1-score reached, on
average, 94% for ACD and 92% for ICD. However, the mean
F1-score for the BL class was 84%. The biomarkers were vali-
dated by real-time qPCR in a small independent group of pa-
tients, confirming expression levels as identified by the
microarrays (Fig. 5A). Technical validation of all samples by real-
time qPCR is shown in SI Appendix, Fig. S8.
Testing of Identified Gene Sets in Independent Datasets Confirms
Predictive Potential of the Biomarkers. Selected gene sets were
tested on microarray gene-expression data derived from two
previously published, independent omics studies (8, 14). First, an
RF-based classifier with 500 trees was trained for each of the 28
selected biomarker sets by using the entire gene-expression
datasets (89 samples) provided in this study. The resulting
trained models were then tested in the external microarray
datasets. The study by Dhingra et al. (8) (dataset GSE60028,
available from Geo DataSets, NCBI) includes gene-expression
profiles induced by contact sensitizers (i.e., NI, fragrance, and
rubber) compared with petrolatum. The rationale to test this
external dataset was to assess the generalizability of the selected
biomarker models on new, untested samples. In our analysis, two
biomarker models (“CD47, PRC1” and “PRC1, RGS16,
SYNPO”) achieved good prediction results (80%). Importantly,
we observed that the two biomarker sets correctly classified NI-,
thiuram-, and fragrance-exposed samples (Fig. 5B and SI Ap-
pendix, Table S4), two of which (thiuram and fragrance mix)
were not used by us for biomarker identification.
Furthermore, a study by Fyhrquist et al. (14) (available from
EBI ArrayExpress under accession E-MTAB-8149), provided
gene-expression profiles from BL samples, lesional and nonle-
sional skin in psoriasis and atopic dermatitis. The second exter-
nal testing dataset was particularly useful for assessing the






























T cells CD4 memory activated
Macrophages M2
T cells CD4 memory resting
T cells CD4 naive
T cells CD8 naive
T cells follicular helper
T cells gamma delta
T cells regulatroy Tregs
Mast cells resting NK cells activated
Macrophages M1 Macrophages M2 Mast cells activated




































BL NO SL EP CM NI PP BL NO SL EP CM NI PP
BL NO SL EP CM NI PP BL NO SL EP CM NI PP BL NO SL EP CM NI PP




















Baseline Irritant CD Allergic CD
Fig. 2. CIBERSORT analysis of the accumulation of leukocytes in treated skin areas based on the transcriptomes. (A) Overview of estimated cell fractions from
gene-expression signatures. (B) Significantly changed estimated cell populations after chemical exposure. Boxplots display the mean and ± SD of estimated
cell fractions. P values were generated by CIBERSORT using Monte Carlo sampling and the null hypothesis was tested by Pearson correlation. *P < 0.01; **P <
0.001; ***P < 0.0001; ****P < 0.00001.
































uncertainty of the trained classifiers when they are tested on
gene-expression profiles of psoriasis or atopic dermatitis sam-
ples. This is important from the point of view that both psoriasis
and atopic dermatitis frequently confound ACD and ICD diag-
nostics, and consequently, biomarkers for ACD or ICD should
be disease specific and not recognize other skin inflammatory
conditions (7, 11). In our assessment, 10 of the biomarker sets
performed as expected in the dataset by Fyhrquist et al. (14), by
classifying control samples accurately as BL, while psoriasis and
atopic dermatitis nonlesional and lesional skin remained un-
classified (Fig. 5C and SI Appendix, Table S5). More technical
details on external validation tests are reported in SI Appendix.
The Identified Biomarkers and Immune Cell Infiltration Are Associated
with Clinical Severity. The strength of the reactions to the contact
sensitizers, as determined by the dermatologists, associated with
the extent of gene expression: That is, the more severe the reac-
tion, the higher the number of dysregulated genes (SI Appendix,
Fig. S9A). To ensure that the identified biomarkers are applicable
in all degrees of inflammation, ranging from mild to severe re-
actions, we investigated their expression in each severity category
and found that even in the mildest reactions, all identified bio-
markers were significantly induced, and their expression levels
correlated positively with the strength of the reaction (Fig. 6A and
SI Appendix, Fig. S9 B and C). Moreover, we performed a time-
course analysis limited to NI+ reactions, observing the kinetics of
the expression of three of the identified biomarkers: CD47, BATF,
and FASLG. None of them were induced at early time points (2
h), but potently expressed at 48 h, and maintained throughout 96 h
postexposure (Fig. 6B). The expression of a selection of genes
after allergen or irritant exposure, related to the strength of the
reaction, is illustrated in Fig. 6C. Finally, correlating the accu-
mulation of leukocytes (estimated by deconvolution analysis of the
transcriptome) in the treated skin areas with reaction strength,
revealed associations with activated memory CD4 T cells and
activated NK cells, respectively (Fig. 6D). Intriguingly, our analysis
shows a clear dependence on NK cells in ACD, but not in ICD,
whereas both reactions associate with activated CD4 memory
T cells (Fig. 6D), primarily driven by the contrast between the
baseline and the positive reactions.
Confirmation of Leukocyte Compositional Changes by Immunohistochemical
Analyses. A second skin biopsy sample was collected from the same
skin sites for comparative histological analyses. Chemical-exposed tis-
sues displayed clearly visible perivascular accumulation of lymphocytes
and inflammatory involvement of the epidermis (Fig. 7A). Immuno-
histochemical (IHC) staining and analysis using neural network-based
algorithms for recognition of positively stained cells in the tissue,
revealed statistically significant accumulation of CD3+, CD4+, and
CD8+ cells in the reactions to contact sensitizers (Fig. 7B and SI
Appendix, Table S6). Moreover, a significant association was observed
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Fig. 3. The grouping of transcriptomes. The clustering of samples was analyzed by (A) using PCA and k-means algorithms, and by (B) hierarchical clustering,
revealing three clearly separated groups; ACD, ICD, and BL. Reaction strength is graded +, ++, or +++ and IR, IR1, and IR2 for ACD and ICD reactions, re-
spectively. In this figure, the reaction strength of BL samples (no reaction) is called “B.” (C) Venn diagram illustrating overlaps of DEGs between ACD and BL,
ICD and BL, and ACD and ICD.






















and severity in ACD (Fig. 7C), supporting our transcriptomics-based
analyses. The association between severity of the response to irritants
and the inflammatory infiltrate was nonsignificant, likely due to a low
number of samples in the high severity categories (SI Appendix, Fig.
S10). SI Appendix, Fig. S11 illustrates the recognition of positively
stained cells by deep learning algorithms.
Discussion
Distinguishing ACD from skin irritation and other dermatoses
remains a challenge to dermatologists, and therefore searching
for biomarkers that reliably differentiate between the two con-
ditions is essential. Using integrative transcriptome analysis and
machine-learning–driven biomarker discovery, we identified ro-
bust gene sets for the distinction between the two highly inter-
woven diseases. We tested these biomarker sets in an
independent patient group suffering from CD and demonstrate
their potential applicability in reactions induced by agents dif-
ferent from those that were used for biomarker discovery. Thus,
we provide high-potential molecular biomarker candidates for
further clinical evaluation.
Just a handful of studies have explored the skin for diagnostic
markers, and many of them have evaluated only a limited
number of markers. A study by Corsini and Galli (15) focused on
cytokines and chemokines for the differentiation between ICD
and ACD and concluded that while both allergens and irritants
induce TNF, GM-CSF, and IFN-γ, instead IL-1A, IL-12 and IL-
1B might be useful for the identification of skin allergen-induced
reactions. Furthermore, Meller et al. (16) suggested that T cell-
driven chemokines, such as CXCL9, CXCL10, and CXCL11 may
discriminate between ACD and ICD. Later on, the development
of techniques, such as microarray chips and RNA sequencing,
allowed for more extensive gene profiling, resulting in studies
that deepened our understanding of mechanisms and identified
further potential biomarkers. Clemmensen et al. (17) showed
that although the irritants NO and SL elicit widely different
gene-expression profiles in the skin, they shared 23 biomarkers,
which could be used for the identification of cumulative ICD.
Moreover, transcriptomics studies in in vitro models developed
for chemical safety testing have pinpointed sets of genes that may
distinguish between sensitizing and irritant compounds, at least
in simplified in vitro models (18). Finally, Dhingra et al. (8) have
reported unique gene-activation patterns between a selection of
contact sensitizers, concluding that ACD may not be considered
as a single entity. Here, we show that although diverse contact
sensitizers induce slightly different sets of genes, they also share
a remarkable number of common genes, which are distinct from
those stimulated by irritants. This allowed for the identification
of in vivo biomarkers that distinguished between the two
categories—irritants and sensitizers—regardless of the physico-
chemical properties of the inducing agents.
Unsupervised, data-driven analysis of the clustering of the
different exposures gave great promise for biomarker discovery,
for the purpose of distinguishing between the two reaction types,
ACD and ICD. Each agent was assigned to either category, ACD
or ICD, based on the literature. The tested compounds (i.e., EP,
CM, NI, and PP) are well-defined agents that commonly cause
contact allergies in occupational settings (19–23), and the two
irritants, SL and NO, are likewise well-defined skin irritants in
the literature (17, 24). Combining the exposures into single
categories, either ACD or ICD, revealed gene signatures and
functions highly representative of each category, including a
prominent inflammatory response in the former and mainly skin
development and cell cycling in the latter. Furthermore, network
analysis allowed for singling out of important functions and re-
lated genes within the two categories, highlighting cytokine sig-
naling and adaptive immunity in ACD, and cell division and
inflammatory response in ICD. Genes that were assigned the
highest importance within the networks included ADAM8 and
CD47 in ACD and RRM2 and SPC25 in ICD. ADAM8 is im-
plicated in various inflammatory diseases by regulating cell re-
cruitment and activation (25, 26), and likely plays a central role
in angiogenesis (27). CD47 is a widely expressed transmem-
brane protein, particularly in NK cells (28), and is important by
regulating cell migration and phagocytosis, and by promoting
the proliferation of T cells and activation of cytotoxic T lym-
phocytes (CTLs) (29). Finally, the ICD-specific genes, RRM2
and SPC25, are both involved in functions related to cell cycling
(30, 31).
Differential gene expression is important for understanding
the biology underlying allergic skin inflammation and skin irri-
tation, but it is not sufficient to optimally address the biomarker
discovery problem. Methods that identify significant genes by
monovarietal statistical tests (e.g., the empirical Bayes moder-
ated t-statistics), where each gene is considered as independent
from the others, are known to perform poorly in external vali-
dation tests. Instead, multivariate methods enable the identifi-
cation of sets of biomarkers with superior diagnostic and
prognostic performance compared to single markers in the
context of sensitivity, specificity, and robustness, as synergies and
antagonisms between potential biomarkers are taken into con-
sideration. Thus, by using GARBO (32), a wrapper approach
that couples a GA with an RF-based classifier, we identified an
optimal set of biomarkers. The list of biomarkers that this ap-









































Fig. 4. Network analysis of coexpressed genes associated with ACD or ICD.
Networks were inferred based on the transcriptomes identified for positive
patch tests against (A) allergens or (B) irritants. The networks were gener-
ated and visualized using the INfORM platform. Genes were considered
linked in the network, if their expression profiles correlated positively (red
edges) or negatively (blue edges). Modules in the network were defined
based on the similarity of the gene expression profiles, and the indicated
direction of gene expression (black arrow, up-regulated; light grey arrow,
down-regulated) is based on average fold-changes of all genes of each
module. Top enriched functions were identified by using EnrichR.
































genes—including CD47, BATF, FASLG, SELE, and IL37—
suggesting that in addition to being biomarkers with a diagnostic
relevance to distinguish between ACD and ICD, these molecules
play key roles in the pathomechanisms of ACD and may there-
fore also constitute important targets of therapy. The transcrip-
tion factor BATF, for example, is a key regulator of the
differentiation of effector CTLs (33), key players in ACD (34).
Moreover, BATF is critical for the differentiation of Th17 cells
(35), which have been reported to be involved in the immuno-
pathology of ACD (8, 36). Furthermore, FASLG is a central
player in the induction of cell death. By binding to keratinocytes
presenting cognate peptides on their MHC I, CTLs induce
antigen-specific apoptosis via FAS–FASL interactions. In con-
trast, NK cells that accumulate in ACD (37), induce target cell
death by FASL-dependent cytotoxicity in a nonspecific manner
(38). SELE, which encodes E-selectin, in turn, is an important
constituent of the beginning of the process of rolling and homing
of T cells (39). Finally, IL-37 is a potent inhibitor of innate im-
mune signaling, expressed by effector memory T cells and mac-
rophages, and with an established immunoregulatory role in skin
inflammatory disease (40). Thus, the identified biomarkers are
part of highly relevant mechanisms in the context of ACD and
skin inflammation in general. Finally, our analyses revealed the
induction of most biomarkers even in weak reactions to the
causing agents, indicating potential as effective diagnostic indi-
cators of allergic or irritant reactions even in the mildest cases.
Of note, in this study we accept a potential variability in the
grading of severity due to different dermatologists reading the
patch tests, and acknowledge that quantitative measurement of
erythema (by a colorimeter) is warranted in future studies.
In conclusion, our analysis reveals putative key players in CD,
including both common and unique features of ACD and ICD
reactions. While T cell-driven immune signaling is a characteristic
of the ACD response, T cells also participate in ICD responses,
and thus infiltration of T cells per se is a poor differentiator be-
tween the two types of skin inflammation. Instead, the presence of
innate immune cells, such as macrophages and NK cells, and re-
lated signaling makes the difference and is apparently the result of
antigen-specific T cell-driven signaling and cross-talk between the
two arms of immunity, resulting in the amplification of the re-
sponse in ACD. Importantly, the identified biomarkers were val-
idated by qPCR in an independent group of patients and
distinguished between the two conditions with high accuracy in
external datasets (8, 14). The identified sets of genes correctly
categorized a wide range of exposing agents, including chemicals
that were not part of the biomarker identification process.
Moreover, the gene sets did not recognize other types of derma-
toses, such as atopic dermatitis or psoriasis, giving promise for a
robust, reliable, and unique set of biomarkers for differentiating
between ACD and ICD, to be validated further in a prospective
clinical study. Finally, the identified biomarkers represent key
features of skin inflammation and repair, which might—in addi-
tion to serving as biomarkers for diagnostic purposes—prove to be
efficient indicators of disease risk or improvement.
Materials and Methods
Patient Recruitment. Dermatologists at the University of Helsinki and the
Finnish Institute of Occupational Health selected patients (n = 85) to be
included in the study based on patch test readings and clinical history. Pa-
tients over 18 y of age were included in the study, and care was taken to
have age- and gender-matched representation. An independent group of
patients and samples were collected for validation purposes (Fig. 1A). Ex-
clusion criteria included extensive or disseminated eczema or other skin
disorders. Patient characteristics are summarized in Tables 2 and 3 and SI
Table 1. Gene sets selected by GARBO
Accuracy Precision-ACD Precision-BL Precision-ICD Recall-ACD Recall-BL Recall-ICD F1-score-ACD F1-score-BL F1-score-ICD
IL37, SELE 0.9185 0.9412 0.9286 0.8968 0.9412 0.8478 0.9262 0.9412 0.8864 0.9113
BATF, PRC1 0.9222 0.9314 0.9048 0.9206 0.9500 0.8837 0.9.134 0.9406 0.8941 0.9170
BATF, PKMYT1 0.9111 0.9706 0.7857 0.9048 0.9429 0.8462 0.9048 0.9565 0.8148 0.9048
BATF, PBK 0.8926 0.9216 0.8571 0.8810 0.9307 0.8182 0.8880 0.9261 0.8372 0.8845
RAD54L, RGS16 0.8926 0.9314 0.8095 0.8889 0.9406 0.7907 0.8889 0.9360 0.8000 0.8889
BATF, EXO1 0.9074 0.9118 0.9524 0.8889 0.9118 0.8511 0.9256 0.9118 0.8989 0.9069
CD47, PRC1 0.9222 0.9118 0.9286 0.9286 0.9394 0.9286 0.9070 0.9254 0.9286 0.9176
IL37, RGS16 0.8926 0.9216 0.8810 0.8730 0.9400 0.7708 0.9016 0.9307 0.8222 0.8871
KIFC1, RGS16 0.9259 0.9412 0.8571 0.9365 0.9505 0.8182 0.9440 0.9458 0.8372 0.9402
BATF, IL37 0.9111 0.9412 0.9286 0.8810 0.9143 0.8478 0.9328 0.9275 0.8864 0.9061
HIST1H1A, SELE 0.8926 0.9608 0.8571 0.8492 0.9515 0.7200 0.9145 0.9561 0.7826 0.8807
BATF, TPX2 0.9074 0.9412 0.8810 0.8889 0.9320 0.8409 0.9106 0.9366 0.8605 0.8996
PRC1, SELE 0.9185 0.9412 0.8810 0.9127 0.9320 0.8222 0.9426 0.9366 0.8506 0.9274
RGS16, SPC25 0.9148 0.9314 0.8571 0.9206 0.9406 0.8000 0.9355 0.9360 0.8276 0.9280
FASLG, RRM2 0.9296 0.9118 0.8571 0.9683 0.9688 0.8000 0.9457 0.9394 0.8276 0.9569
RRM2, SELE 0.9148 0.9412 0.8571 0.9127 0.9412 0.7347 0.9664 0.9412 0.7912 0.9388
LYPD2, SELE 0.8963 0.9412 0.7857 0.8968 0.9600 0.7857 0.8828 0.9505 0.7857 0.8898
PRC1, PTPN7, RGS16 0.9333 0.9510 0.8810 0.9365 0.9604 0.8409 0.9440 0.9557 0.8605 0.9402
IL37, RRM2, SELE 0.9370 0.9412 0.9286 0.9365 0.9697 0.7800 0.9752 0.9552 0.8478 0.9555
BATF, PRC1, RGS16 0.9259 0.9608 0.8571 0.9206 0.9800 0.7660 0.9431 0.9703 0.8090 0.9317
IL37, PRC1, RGS16 0.9296 0.9412 0.8810 0.9365 0.9697 0.8409 0.9291 0.9552 0.8605 0.9328
PRC1, RGS16, SYNPO 0.9296 0.9608 0.8571 0.9286 0.9703 0.8000 0.9435 0.9655 0.8276 0.9360
PRC1, RGS16, WARS 0.9222 0.9314 0.9048 0.9206 0.9596 0.8444 0.9206 0.9453 0.8736 0.9206
DLGAP5, IL37, SELE 0.9259 0,9510 0.9048 0.9127 0.9327 0.8837 0.9350 0.9417 0.8941 0.9237
IL37, SELE, TPX2 0.9222 0.9412 0.8571 0.9286 0.9412 0.9000 0.9141 0.9412 0.8780 0.9213
IL37, SELE, THBS2 0.9481 0.9804 0.9286 0.9286 0.9709 0.8667 0.9590 0.9756 0.8966 0.9435
LYPD2, PBK, SELE 0.9148 0.9412 0.8571 0.9127 0.9600 0.7500 0.9426 0.9505 0.8000 0.9274
BATF, CH25H, PRC1 0.9185 0.8922 0.8810 0.9524 0.9681 0.8409 0.9091 0.9286 0.8605 0.9302
The feature selection process coupled with RF-based classifiers enables the discovery of sets of biomarkers that together can guarantee the classification of
the samples in the three classes, BL, ACD, and ICD. The table shows the classification accuracy and its SD calculated on the training and test sets. The stability
indicates the occurrence frequency of each model across the five runs.






















Appendix, Table S7. Skin preparation instructions included avoiding the
application of topical emollients for 24 h and topical medication for 2 wk at
sampling sites prior to the sampling time point. The experimental protocol
followed the Declaration of Helsinki principles and was approved by the
Ethics Committee of Helsinki University Central Hospital (approval numbers
43/13/03/00/14 and §214/3.9.2014, dnro 171/13/03/01/2014). All participants
signed an informed consent form.
Patient Sample Collection. Patch testing was performed in accordance with
the European Society of Contact Dermatitis guidelines (11) for four allergens
(1% EP, 1% PP, 0.02% CM, and 5% NI; Chemotechnique) and two irritants
(2% SL, 17.5% NO). A detailed description of the procedure is described in SI
Appendix. Two 3-mm punch biopsies were obtained from the test areas
when a reaction was seen. From each subject a total of four 3-mm biopsies




















































































































































































Microarray Real time qPCR
Fig. 5. Validation of biomarkers selected by GARBO. (A) Expression levels of selected biomarkers measured by arrays (panels on the Left) and validated by
real time qPCR in an independent group of patients (panels on the Right). Error bars correspond to SD. Selected combinations of biomarkers were tested in
external datasets of (B) ACD (access code GSE60028) and (C) atopic dermatitis (AD) and psoriasis (PSO) (access code E-MTAB-8149), revealing predictive
potential of the biomarkers, reported as the frequency of correct prediction. GSE60028 was used to demonstrate the generalizability of the selected bio-
marker models on new, external ACD samples; the second external testing dataset (E-MTAB-8149) aimed to prove the uncertainty of the biomarker models
when trying to classify lesional and nonlesional skin in psoriasis and atopic dermatitis.
































reaction. Moreover, biopsies were collected from healthy skin (HS). One bi-
opsy was immersed in RNAlater liquid and stored at −80 °C until further
analysis. The second 3-mm biopsy was fixed in formalin and embedded in
paraffin for screening and validation of biomarkers by IHC. Negative ACD
reactions were collected from part of the patients to represent BL samples,
because of a limit to the ethical permit. HS samples were obtained under a
different ethical permit. A comparison of the negative reactions and HS
showed that gene-expression levels between these two categories were fully
comparable (SI Appendix, Fig. S12), and thus, negative reactions and HS
were considered as BL samples.
Transcriptomics Data Generation and Analysis. DNA and RNA were extracted
from skin biopsies stored in RNAlater solution using the AllPrep DNA/RNA
mini kit (Qiagen) according to the manufacturers’ instructions and only
samples with an RNA integrity number > 8 were used for further analysis.
SurePrint G3 Human Gene Expression Microarrays (Agilent) were used for
transcriptomic analysis according to the manufacturers’ instructions. A de-
tailed description is provided in SI Appendix, Supplementary Methods.
Genes were defined as being differentially expressed after fulfilling the
requirements of a minimum fold-change of ±1.5 and a maximum,
Benjamini–Hochberg-adjusted, P value of 0.05.
Unsupervised Exploratory Analysis. Samples were grouped according to their
expression profiles by using k-mean (with k = 3) and hierarchical clustering
algorithms. PCA and heat maps were used to visualize the grouping. PCA
was applied to the entire gene-expression datasets, while the heat map was
generated using the expression profiles of DEGs across the different com-
































































































































































R = 0.7, p = 7e−09 R = 0.74, p = 5.2e−10
NK cells activated T cells CD4 memory activated





















R = − 0.26, p = 0.051 R = 0.65, p = 3.1e−08
NK cells activated T cells CD4 memory activated














































Irritant CD Allergic CD
Fig. 6. Biomarker expression and leukocyte infiltration as a function of severity and time. (A) The expression of selected biomarkers in response to NI (Upper)
and EP (Lower) relative to severity. P values were generated by unpaired t test and error bars correspond to SD. (B) The expression of selected biomarkers at
time points 2, 48, and 96 h after NI exposure. (C) An overview of ACD and ICD associated key genes in relation to reaction strength (allergic reactions graded
+, ++, or +++; irritant reactions graded IR, IR1, or IR2). (D) Spearman’s rank correlation between the proportion of immune cells (estimated by deconvolution
analysis of transcriptomes) and reaction strengths reveal dependence of both ACD and ICD on activated CD4 memory T cells, but of ACD only, on activated
NK cells.






















Leukocyte Deconvolution. The CIBERSORT algorithm (41) was applied to the
gene-expression data to estimate the leukocyte subset proportions of 22
individual immune cells utilizing the “LM22” validated gene-signature ma-
trix as provided from the algorithm. Estimations are based on 1,000 per-
mutations. No significance filter has been applied to the estimated cell
fractions to include all samples for further analysis. Correlations between
the proportions of leukocytes and reaction strengths were explored by
Spearman’s rank correlation (R package ggpubr) (42).
INfORM. INfORM was applied to generate coexpression networks and to
identify gene modules associated with the biological processes and regula-
tory mechanisms differentiating the expression and regulation of ACD and
ICD. First, a robust gene coexpression network was derived by combining
multiple networks inferred from the gene-expression profiles. The com-
pendium of gene networks was generated by using different network in-
ference algorithms, including ARACNE (43), MRNET (44), CLR (45), and
mutual information-based methods (46). The compiled networks were then
merged to define an ensemble gene network that includes only high-
confidence edges. A detailed description of the adopted network integra-
tion strategy can be found in Marwah et al. (13). Second, gene modules were
identified in the network by using community detection algorithms and
evaluated based on multiple metrics of node importance. The genes within
each module were then ranked based on their centrality scores, differential
log2 (fold-change), and differential P value. Moreover, enrichment analysis
was performed to find the GO terms overrepresented in each module and
compute the similarity between sets of GO terms from different modules.
Biomarker Discovery. A supervised machine-learning–based approach was
used in order to identify sets of genes (or composite biomarkers) whose
expression can jointly classify (or distinguish) skin biopsy samples into three
groups: ACD, ICD, and BL. Each sample gene-expression profile was first
labeled as ACD, ICD, or BL, based on the patch test results. True positive
patch testing results against EP, PP, CM, or NI were labeled as ACD, while
true positive patch testing results against SL and noncorrosive irritant NO
were labeled as ICD. Negative ACD reactions were used to represent BL
samples. In order to address the defined ternary ( classes) classification
problem, we applied GARBO (32). GARBO implements a wrapper GA cou-
pled with RF-based classifiers in order to search for composite biomarkers
that yield the minimum number of genes with maximum accuracy. If one
gene is good enough to distinguish the three classes (ACD, ICD, or BL), then
GARBO will identify biomarker panels consisting of one feature or gene.
However, if GARBO finds biomarker panels including two or more than two
genes, then this means that a composite (or multivariate) biomarker model
is needed to obtain the highest classification scores. The proposed feature
selection strategy is evaluated with fivefold cross-validation in order to
simulate different training sets and test the selected gene sets on unseen
data. The classification performances are measured using Precision, Recall,
F-Measure, and Accuracy rate. Moreover, independent gene-expression
datasets are used in order to evaluate the performance of the trained
classifiers on independent datasets.
qPCR. Validation of biomarkers was performed by real-time qPCR in a sep-
arate group of patients. mRNA levels of BATF, PRC1, CD47, EXO1, FASLG,
and RRM2 (SI Appendix, Table S8) were analyzed by quantitative RT-PCR
using Taqman chemistry and the 7500 Fast Real-Time PCR System (Applied
Biosystems, Life Technologies). A detailed description is provided in SI Ap-
pendix, Supplemental Methods. The results are expressed as relative units
(RU), which was calculated by the comparative CT method according to the
manufacturer’s instructions (47). Statistical significance was assessed by one-
way ANOVA, and P values of <0.05 were considered significant. Statistical
analysis and creation of graphs were done in PRISM 8 OS X (GraphPad) and
results are presented as ±SD.
Histology and IHC. Paraffin-embedded, 4-μm-thick skin tissue sections were
stained for CD3 (RTU, clone 2GV6, Roche 790-4341), CD4 (1:100 clone SP35,
Cell Marque, 104R-16), and CD8 (1:50, clone 4B11, Novocastra, NCL-L-CD8-
4B11), using the Ventana Benchmark Ultra instrument (Roche). Tissue sec-
tions were pretreated in cell conditioning 1 buffer (pH 8.5) (Roche 950-124)
at 98 °C for 64 min, followed by incubation with the antibodies at 37 °C for





























































































Fig. 7. IHC staining of chemical exposed human skin. (A) Representative images of BL, SL-, PP-, and EP-exposed samples (original magnification ×10) dis-
playing a larger infiltration of CD3+, CD4+, and CD8+ cells in response to allergen exposure (PP and EP). (B) Positively stained cells identified by deep learning
algorithms for each exposure group. Groups were compared using Dunn’s multiple comparison test (results available in SI Appendix, Table S6). (C) Significant
association between T lymphocyte infiltration and the severity of the reaction (graded +, ++, and +++). Statistical analysis was performed using Mann–
Whitney U test and P values of <0.05 were considered significant. Boxplots display mean, and first and third quartiles.




Gender F/M Age mean ± SD+ ++ +++
CM 17 11 6 0 10/7 36 ± 13
EP 12 6 1 5 4/8 43 ± 14
NI 11 3 4 4 10/1 38 ± 15
PP 7 3 1 3 7/0 40 ± 15
The severity of allergic reactions is graded +, ++, or +++. F, female;
M, male.
































44 min. The multimer-based detection kit, Ultraview (Roche 760-700) was
used for the detection of CD3, and CD8. Optiview (Roche 760-700) was used
to detect CD4. The reactions were visualized with diaminobenzidine (DAB)
and counterstained with hematoxylin.
Digitization of Samples. The anti-CD3, anti-CD8, and anti-CD4 immunostained
skin biopsy slides were digitized with a whole-slide scanner (Pannoramic 250
FLASH, 3DHISTECH) equipped with a 20× objective (numerical aperture 0.8)
and a 1× adapter, and a global shutter CMOS camera with 4,096 × 3,072
pixels sized 5.5 μm × 5.5 μm (Adimec QUARTZ Q-12A180 camera), resulting in
an image in which one pixel represents an area of 0.24 μm × 0.24 μm. Images
were stored in a whole slide image format (MRX, 3DHISTECH) and further
compressed to a wavelet file format (Enhanced Compressed Wavelet, ECW,
ER Mapper, Intergraph) with a target compression ratio of 1:10. The com-
pressed virtual slides were uploaded to a whole-slide image management
server (Aiforia Technologies Oy).
Deep Learning-Based Algorithms for Detecting Immunostained Tissue Areas.
The two convolutional neural network-based algorithms (48) were trained
using cloud-based software (Aiforia Create, Aiforia Technologies Oy) for
image analysis to separately identify tissue areas, as well as the areas stained
with DAB, which was used as chromogen for the detection of specific anti-
CD3, anti-CD4, and anti-CD8 antigen. The algorithm involves two algorithms
in sequence, the first segmenting the tissue areas and the second identifying
DAB-stained areas which reflect specific immunostainings. The deep learn-
ing network for the detection of tissue areas was trained on anti-CD8
immunostained tissue slides on 35 samples across the expositions as well
as the BL. The 500 image annotations used for training the algorithm for the
tissue layer corresponded to an area of 1.13-mm2 tissue. The algorithm for
detecting anti-CD8 stained areas was trained across 67 samples with 430
image annotations corresponding to an area of 0.053-mm2 tissue. We used a
feature size of 100 μm for training the algorithm for detection of the tissue
areas and feature size of 20 μm for training the areas with CD8 expression.
The augmentation parameters for detection of tissue were 0° to 360° ro-
tation, ±30% scale, ±20% aspect ratio change, ±20% shear distortion, ±20%
luminance, and ±20% contrast change and augmentation parameters for
the detection of CD8 expression were 0° to 360° rotation, ±10% scale, ±20%
aspect ratio change, ±20% shear distortion, ±1% luminance, and ±1%
contrast change. All data were flipped both vertically and horizontally. The
final algorithms were trained for 10,000 iterations. The same algorithms that
were trained for detecting anti-CD8 immunostained tissue areas (SI Ap-
pendix, Fig. S11) were used for detecting CD3 and CD4. Prism 8 OS X
(GraphPad) and R Studio (v1.2.5001) were used to perform statistical anal-
yses and create graphs (R package ggpubr and ggplot2). Statistical analysis
included Dunn’s multiple comparisons test and Mann–Whitney U test, and P
values of <0.05 were considered significant.
Data Availability.Original expression microarray data have been deposited in
the ArrayExpress, https://www.ebi.ac.uk/arrayexpress/ (accession no. E-MTAB-9501).
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